Table 5.

Comparison of inflammatory markers (x̅±sd, pg/ml)

Group	IL-6		MCP-1
	Before Treatment	After Treatment	Before Treatment	After Treatment
Early SGLT2-i group (n = 88)	19.68±3.25	11.07±2.59*	142.36±15.75	51.28±6.49*
Late SGLT2-i group (n = 90)	20.45±3.71	12.04±2.60*	142.95±16.02	63.79±7.33*
t	1.472	2.493	0.248	12.046
P	0.143	0.014	0.805	< 0.001

^*P < 0.05 compared to pre-treatment within the same group;

IL-6, Interleukin-6; MCP-1, Monocyte Chemoattractant Protein-1; SGLT2-i, sodium-glucose cotransporter 2 inhibitor.